Medical director

Better risk stratification and lower hospital costs

The suPARnostic® test provides improved risk stratification of all patients in the Emergency Department.
This allows the staff to discharge more non-acute patients earlier, to reduce stress, crowding and hospital costs. It also generates more time for the staff to focus on high-risk patients, enabling them to provide even better clinical care.

Eliminate doubt in clinical decisions

suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum. It enables Healthcare Professionals to make fast clinical decisions based on prognostic evidence across diseases.

A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.

Get More Info

Documented by 600+ publications

Here you can find a short summary of the research done on suPAR within 12 groups of disease areas and see how the suPAR level is affected within each type of disease.

suPAR Publications
Disease Areas